PMID: 9427429Jan 14, 1998Paper

Second cancers after medulloblastoma: population-based results from the United States and Sweden

Cancer Causes & Control : CCC
A M GoldsteinM A Tucker

Abstract

Medulloblastoma, one of the most common central nervous system (CNS) tumors in children, requires aggressive multimodality therapy including surgery, radiation therapy, and occasionally chemotherapy. Given its intensive treatment regimen and improved survival during the past 20 years, it is likely that a cohort of survivors will result who may incur consequences of therapy, including a second cancer. We used population-based data from the United States and Sweden to estimate risks of second neoplasms in patients with histologically confirmed medulloblastoma (n = 1,262). Overall, there was a 5.4-fold excess of second neoplasms (95 percent confidence interval = 3.3-8.4) based on 20 observed and 3.7 expected cancers. The second cancers occurred eight to 432 months after initial diagnosis (median, 73 months) with significantly elevated ratios for all intervals examined except for less than one year after initial diagnosis. Significantly elevated risks were seen for cancers of the salivary glands, cervix uteri, brain and CNS, thyroid gland, and acute lymphoblastic leukemia. Of the 15 second cancers with treatment data, seven occurred in the radiation field or within areas of scatter while two others may have been radiation-related. ...Continue Reading

Citations

Aug 2, 2005·Archives of Environmental Health·Edward C HalperinMatthew Stanberry
Apr 9, 2008·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Benedetta Ludovica PettoriniConcezio Di Rocco
Mar 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matija SnuderlStephen Yip
Feb 26, 2014·Acta Oncologica·Kaitlin M ChristophersonDaniel J Indelicato
Mar 5, 2019·The Journal of Craniofacial Surgery·Giacomo OteriAntonia Marciano
Mar 10, 2001·Medical and Pediatric Oncology·K CasteelsA Uyttebroeck
May 8, 2001·Medical and Pediatric Oncology·P D Inskip
Mar 7, 2002·Journal of Pediatric Hematology/oncology·T StavrouG H Reaman
Aug 7, 2003·Journal of Pediatric Hematology/oncology·Thomas LehrnbecherJoachim Kühl
Feb 3, 2005·Pediatric Neurosurgery·Kamil Melih AkayErdener Timurkaynak
Mar 30, 2006·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Andrew J HopeJoseph R Simpson
Oct 10, 2007·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Maria MoschoviEleni Th Petridou
Mar 17, 2011·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Matthieu VinchonIsabelle Delestret
Jul 31, 2012·Oral and Maxillofacial Surgery·Tobias EttlTorsten E Reichert
Jan 25, 2020·Acta Paediatrica·Einar StensvoldPetter Brandal
Nov 30, 1999·Critical Reviews in Neurosurgery : CR·A Todd, J Ruge
Jul 28, 2007·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Yavuz KoksalM Erkan Ustun
Dec 17, 2008·Pediatric Radiology·Ruth A Kleinerman
May 25, 2012·Current Treatment Options in Neurology·Katja von Hoff, Stefan Rutkowski
Jun 27, 2019·Current Treatment Options in Oncology·Nazanin Majd, Marta Penas-Prado
Sep 17, 2003·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Elida VázquezJavier Lucaya
Sep 7, 2012·Neuro-oncology·Melissa Z BraganzaPreetha Rajaraman
Apr 1, 2008·Journal of Neuro-oncology·Takashi SasayamaEiji Kohmura
Apr 3, 2003·Current Treatment Options in Neurology·Catherine A. Mazzola, Ian F. Pollack
Jun 1, 2016·Pediatric Dermatology·Jamie L MullSusan J Bayliss
Mar 27, 2013·Nature Reviews. Clinical Oncology·Lois B TravisAndrea K Ng
Oct 7, 2016·Neurosurgical Review·Ryuya YamanakaTomohiko Kanayama
Jun 3, 2020·Critical Reviews in Oncology/hematology·Gemma GattaFranz Josef Prott

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.